nodes	percent_of_prediction	percent_of_DWPC	metapath
Ticagrelor—CYP3A4—Temozolomide—malignant glioma	0.644	1	CbGbCtD
Ticagrelor—Haemorrhage intracranial—Temozolomide—malignant glioma	0.0164	0.0592	CcSEcCtD
Ticagrelor—Transient ischaemic attack—Temozolomide—malignant glioma	0.0134	0.0481	CcSEcCtD
Ticagrelor—Cerebral haemorrhage—Carmustine—malignant glioma	0.0126	0.0454	CcSEcCtD
Ticagrelor—Cerebral haemorrhage—Temozolomide—malignant glioma	0.0122	0.0438	CcSEcCtD
Ticagrelor—Nephropathy toxic—Carmustine—malignant glioma	0.0121	0.0437	CcSEcCtD
Ticagrelor—Lung disorder—Temozolomide—malignant glioma	0.00952	0.0343	CcSEcCtD
Ticagrelor—Vaginal haemorrhage—Temozolomide—malignant glioma	0.00911	0.0328	CcSEcCtD
Ticagrelor—Petechiae—Temozolomide—malignant glioma	0.00819	0.0295	CcSEcCtD
Ticagrelor—Gynaecomastia—Carmustine—malignant glioma	0.00624	0.0225	CcSEcCtD
Ticagrelor—Gastrointestinal haemorrhage—Carmustine—malignant glioma	0.00506	0.0182	CcSEcCtD
Ticagrelor—Breast disorder—Temozolomide—malignant glioma	0.00442	0.0159	CcSEcCtD
Ticagrelor—Haemoglobin—Carmustine—malignant glioma	0.00352	0.0127	CcSEcCtD
Ticagrelor—Haemorrhage—Carmustine—malignant glioma	0.0035	0.0126	CcSEcCtD
Ticagrelor—Oedema peripheral—Carmustine—malignant glioma	0.00345	0.0124	CcSEcCtD
Ticagrelor—Connective tissue disorder—Carmustine—malignant glioma	0.00344	0.0124	CcSEcCtD
Ticagrelor—Haemoglobin—Temozolomide—malignant glioma	0.0034	0.0122	CcSEcCtD
Ticagrelor—Haemorrhage—Temozolomide—malignant glioma	0.00338	0.0122	CcSEcCtD
Ticagrelor—Urinary tract disorder—Temozolomide—malignant glioma	0.00334	0.012	CcSEcCtD
Ticagrelor—Oedema peripheral—Temozolomide—malignant glioma	0.00333	0.012	CcSEcCtD
Ticagrelor—Connective tissue disorder—Temozolomide—malignant glioma	0.00333	0.012	CcSEcCtD
Ticagrelor—Urethral disorder—Temozolomide—malignant glioma	0.00332	0.0119	CcSEcCtD
Ticagrelor—Eye disorder—Carmustine—malignant glioma	0.00327	0.0118	CcSEcCtD
Ticagrelor—Eye disorder—Temozolomide—malignant glioma	0.00316	0.0114	CcSEcCtD
Ticagrelor—Cardiac disorder—Temozolomide—malignant glioma	0.00314	0.0113	CcSEcCtD
Ticagrelor—Angiopathy—Temozolomide—malignant glioma	0.00307	0.0111	CcSEcCtD
Ticagrelor—Mental disorder—Carmustine—malignant glioma	0.00307	0.011	CcSEcCtD
Ticagrelor—Immune system disorder—Temozolomide—malignant glioma	0.00306	0.011	CcSEcCtD
Ticagrelor—Mediastinal disorder—Temozolomide—malignant glioma	0.00305	0.011	CcSEcCtD
Ticagrelor—Malnutrition—Carmustine—malignant glioma	0.00305	0.011	CcSEcCtD
Ticagrelor—Mental disorder—Temozolomide—malignant glioma	0.00297	0.0107	CcSEcCtD
Ticagrelor—Back pain—Carmustine—malignant glioma	0.00295	0.0106	CcSEcCtD
Ticagrelor—Malnutrition—Temozolomide—malignant glioma	0.00295	0.0106	CcSEcCtD
Ticagrelor—Back pain—Temozolomide—malignant glioma	0.00285	0.0103	CcSEcCtD
Ticagrelor—Angioedema—Temozolomide—malignant glioma	0.00269	0.00969	CcSEcCtD
Ticagrelor—Vertigo—Temozolomide—malignant glioma	0.00265	0.00953	CcSEcCtD
Ticagrelor—Hypertension—Carmustine—malignant glioma	0.00263	0.00948	CcSEcCtD
Ticagrelor—Chest pain—Carmustine—malignant glioma	0.0026	0.00935	CcSEcCtD
Ticagrelor—Cough—Temozolomide—malignant glioma	0.00257	0.00926	CcSEcCtD
Ticagrelor—Hypertension—Temozolomide—malignant glioma	0.00254	0.00916	CcSEcCtD
Ticagrelor—Confusional state—Carmustine—malignant glioma	0.00251	0.00903	CcSEcCtD
Ticagrelor—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—malignant glioma	0.00249	0.00897	CcSEcCtD
Ticagrelor—Confusional state—Temozolomide—malignant glioma	0.00242	0.00873	CcSEcCtD
Ticagrelor—Nervous system disorder—Temozolomide—malignant glioma	0.00236	0.00849	CcSEcCtD
Ticagrelor—Skin disorder—Temozolomide—malignant glioma	0.00234	0.00841	CcSEcCtD
Ticagrelor—Hypotension—Carmustine—malignant glioma	0.00233	0.00837	CcSEcCtD
Ticagrelor—Paraesthesia—Carmustine—malignant glioma	0.00223	0.00804	CcSEcCtD
Ticagrelor—Dyspnoea—Carmustine—malignant glioma	0.00222	0.00799	CcSEcCtD
Ticagrelor—Paraesthesia—Temozolomide—malignant glioma	0.00216	0.00777	CcSEcCtD
Ticagrelor—Gastrointestinal disorder—Carmustine—malignant glioma	0.00215	0.00773	CcSEcCtD
Ticagrelor—Dyspnoea—Temozolomide—malignant glioma	0.00214	0.00772	CcSEcCtD
Ticagrelor—Constipation—Carmustine—malignant glioma	0.00213	0.00766	CcSEcCtD
Ticagrelor—Dyspepsia—Temozolomide—malignant glioma	0.00212	0.00762	CcSEcCtD
Ticagrelor—Gastrointestinal disorder—Temozolomide—malignant glioma	0.00208	0.00747	CcSEcCtD
Ticagrelor—Fatigue—Temozolomide—malignant glioma	0.00207	0.00746	CcSEcCtD
Ticagrelor—Constipation—Temozolomide—malignant glioma	0.00206	0.0074	CcSEcCtD
Ticagrelor—Feeling abnormal—Carmustine—malignant glioma	0.00205	0.00738	CcSEcCtD
Ticagrelor—Gastrointestinal pain—Carmustine—malignant glioma	0.00203	0.00733	CcSEcCtD
Ticagrelor—Feeling abnormal—Temozolomide—malignant glioma	0.00198	0.00713	CcSEcCtD
Ticagrelor—Body temperature increased—Carmustine—malignant glioma	0.00197	0.00708	CcSEcCtD
Ticagrelor—Abdominal pain—Carmustine—malignant glioma	0.00197	0.00708	CcSEcCtD
Ticagrelor—Gastrointestinal pain—Temozolomide—malignant glioma	0.00197	0.00708	CcSEcCtD
Ticagrelor—Abdominal pain—Temozolomide—malignant glioma	0.0019	0.00684	CcSEcCtD
Ticagrelor—Body temperature increased—Temozolomide—malignant glioma	0.0019	0.00684	CcSEcCtD
Ticagrelor—Hypersensitivity—Carmustine—malignant glioma	0.00183	0.0066	CcSEcCtD
Ticagrelor—Asthenia—Carmustine—malignant glioma	0.00179	0.00643	CcSEcCtD
Ticagrelor—Hypersensitivity—Temozolomide—malignant glioma	0.00177	0.00638	CcSEcCtD
Ticagrelor—Asthenia—Temozolomide—malignant glioma	0.00173	0.00621	CcSEcCtD
Ticagrelor—Diarrhoea—Carmustine—malignant glioma	0.0017	0.00613	CcSEcCtD
Ticagrelor—Pruritus—Temozolomide—malignant glioma	0.0017	0.00613	CcSEcCtD
Ticagrelor—Dizziness—Carmustine—malignant glioma	0.00165	0.00592	CcSEcCtD
Ticagrelor—Diarrhoea—Temozolomide—malignant glioma	0.00165	0.00592	CcSEcCtD
Ticagrelor—Dizziness—Temozolomide—malignant glioma	0.00159	0.00573	CcSEcCtD
Ticagrelor—Vomiting—Carmustine—malignant glioma	0.00158	0.0057	CcSEcCtD
Ticagrelor—Rash—Carmustine—malignant glioma	0.00157	0.00565	CcSEcCtD
Ticagrelor—Dermatitis—Carmustine—malignant glioma	0.00157	0.00564	CcSEcCtD
Ticagrelor—Headache—Carmustine—malignant glioma	0.00156	0.00561	CcSEcCtD
Ticagrelor—Vomiting—Temozolomide—malignant glioma	0.00153	0.0055	CcSEcCtD
Ticagrelor—Rash—Temozolomide—malignant glioma	0.00152	0.00546	CcSEcCtD
Ticagrelor—Dermatitis—Temozolomide—malignant glioma	0.00151	0.00545	CcSEcCtD
Ticagrelor—Headache—Temozolomide—malignant glioma	0.00151	0.00542	CcSEcCtD
Ticagrelor—Nausea—Carmustine—malignant glioma	0.00148	0.00532	CcSEcCtD
Ticagrelor—Nausea—Temozolomide—malignant glioma	0.00143	0.00514	CcSEcCtD
Ticagrelor—P2RY12—GPCR ligand binding—KNG1—malignant glioma	0.000433	0.00556	CbGpPWpGaD
Ticagrelor—CYP3A4—Phase 1 - Functionalization of compounds—CYP2B6—malignant glioma	0.000432	0.00554	CbGpPWpGaD
Ticagrelor—P2RY12—Platelet activation, signaling and aggregation—AKT2—malignant glioma	0.000426	0.00546	CbGpPWpGaD
Ticagrelor—ABCB1—Allograft Rejection—IL12B—malignant glioma	0.000424	0.00544	CbGpPWpGaD
Ticagrelor—P2RY12—Platelet activation, signaling and aggregation—PIK3CD—malignant glioma	0.000409	0.00524	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR downstream signaling—CCR4—malignant glioma	0.000396	0.00508	CbGpPWpGaD
Ticagrelor—P2RY12—Hemostasis—KNG1—malignant glioma	0.000388	0.00497	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—STMN1—malignant glioma	0.000385	0.00493	CbGpPWpGaD
Ticagrelor—P2RY12—Hemostasis—IFNA2—malignant glioma	0.00038	0.00487	CbGpPWpGaD
Ticagrelor—CYP3A4—Phase 1 - Functionalization of compounds—CYP2C18—malignant glioma	0.000375	0.00481	CbGpPWpGaD
Ticagrelor—P2RY12—Class A/1 (Rhodopsin-like receptors)—F2—malignant glioma	0.000368	0.00472	CbGpPWpGaD
Ticagrelor—P2RY12—Platelet activation, signaling and aggregation—RAF1—malignant glioma	0.000365	0.00468	CbGpPWpGaD
Ticagrelor—P2RY12—Hemostasis—SOD1—malignant glioma	0.00036	0.00461	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—CCR4—malignant glioma	0.00036	0.00461	CbGpPWpGaD
Ticagrelor—P2RY12—Platelet activation, signaling and aggregation—PIK3CB—malignant glioma	0.000356	0.00457	CbGpPWpGaD
Ticagrelor—P2RY12—Hemostasis—PTK2—malignant glioma	0.000331	0.00424	CbGpPWpGaD
Ticagrelor—P2RY12—Platelet activation, signaling and aggregation—IL2—malignant glioma	0.000327	0.0042	CbGpPWpGaD
Ticagrelor—P2RY12—G alpha (i) signalling events—CXCL8—malignant glioma	0.000326	0.00418	CbGpPWpGaD
Ticagrelor—ABCB1—HIF-1-alpha transcription factor network—TERT—malignant glioma	0.000316	0.00405	CbGpPWpGaD
Ticagrelor—CYP3A4—Tryptophan metabolism—CAT—malignant glioma	0.000312	0.004	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—MDK—malignant glioma	0.000307	0.00393	CbGpPWpGaD
Ticagrelor—ABCB1—HIF-1-alpha transcription factor network—HIF1A—malignant glioma	0.000302	0.00387	CbGpPWpGaD
Ticagrelor—ABCB1—Allograft Rejection—PDGFRA—malignant glioma	0.000297	0.00381	CbGpPWpGaD
Ticagrelor—ABCB1—Allograft Rejection—HLA-B—malignant glioma	0.000295	0.00378	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR downstream signaling—CXCR3—malignant glioma	0.000294	0.00377	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—DTX1—malignant glioma	0.000292	0.00375	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—PLK1—malignant glioma	0.000291	0.00374	CbGpPWpGaD
Ticagrelor—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—malignant glioma	0.000284	0.00364	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR ligand binding—F2—malignant glioma	0.00028	0.00359	CbGpPWpGaD
Ticagrelor—P2RY12—Platelet activation, signaling and aggregation—VEGFA—malignant glioma	0.000278	0.00357	CbGpPWpGaD
Ticagrelor—P2RY12—Hemostasis—PDGFB—malignant glioma	0.000278	0.00356	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—WT1—malignant glioma	0.000276	0.00354	CbGpPWpGaD
Ticagrelor—ABCB1—Allograft Rejection—HLA-A—malignant glioma	0.000273	0.00351	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR downstream signaling—BDKRB2—malignant glioma	0.000269	0.00345	CbGpPWpGaD
Ticagrelor—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—malignant glioma	0.000269	0.00345	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—CXCR3—malignant glioma	0.000267	0.00343	CbGpPWpGaD
Ticagrelor—P2RY12—Hemostasis—CAV1—malignant glioma	0.000263	0.00337	CbGpPWpGaD
Ticagrelor—P2RY12—Class A/1 (Rhodopsin-like receptors)—CXCL8—malignant glioma	0.000259	0.00332	CbGpPWpGaD
Ticagrelor—P2RY12—Hemostasis—FN1—malignant glioma	0.000251	0.00321	CbGpPWpGaD
Ticagrelor—P2RY12—Hemostasis—F2—malignant glioma	0.000251	0.00321	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—PML—malignant glioma	0.000246	0.00316	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR downstream signaling—KNG1—malignant glioma	0.000245	0.00314	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—BDKRB2—malignant glioma	0.000245	0.00313	CbGpPWpGaD
Ticagrelor—P2RY12—Hemostasis—PIK3CG—malignant glioma	0.00024	0.00307	CbGpPWpGaD
Ticagrelor—P2RY12—Hemostasis—EGF—malignant glioma	0.000237	0.00304	CbGpPWpGaD
Ticagrelor—P2RY12—Hemostasis—PTPN11—malignant glioma	0.000236	0.00302	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—SUFU—malignant glioma	0.000232	0.00298	CbGpPWpGaD
Ticagrelor—ABCB1—Allograft Rejection—CD80—malignant glioma	0.000231	0.00296	CbGpPWpGaD
Ticagrelor—CYP3A4—Biological oxidations—CYP2B6—malignant glioma	0.00023	0.00294	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—HEY2—malignant glioma	0.00023	0.00294	CbGpPWpGaD
Ticagrelor—CYP3A4—Metapathway biotransformation—CYP2B6—malignant glioma	0.000227	0.0029	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—TOP2A—malignant glioma	0.000225	0.00289	CbGpPWpGaD
Ticagrelor—ABCB1—Transmembrane transport of small molecules—COX8A—malignant glioma	0.000225	0.00288	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—GFAP—malignant glioma	0.000224	0.00287	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—KNG1—malignant glioma	0.000222	0.00285	CbGpPWpGaD
Ticagrelor—P2RY12—Hemostasis—AKT2—malignant glioma	0.000219	0.00281	CbGpPWpGaD
Ticagrelor—P2RY12—Platelet activation, signaling and aggregation—PIK3CA—malignant glioma	0.000217	0.00279	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—SPHK1—malignant glioma	0.000217	0.00278	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—CCR4—malignant glioma	0.000213	0.00272	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—HEY1—malignant glioma	0.000213	0.00272	CbGpPWpGaD
Ticagrelor—P2RY12—Hemostasis—PIK3CD—malignant glioma	0.000211	0.0027	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—HIST1H3B—malignant glioma	0.000206	0.00265	CbGpPWpGaD
Ticagrelor—ABCB1—Transmembrane transport of small molecules—FTH1—malignant glioma	0.000205	0.00263	CbGpPWpGaD
Ticagrelor—CYP3A4—Biological oxidations—CYP2C18—malignant glioma	0.000199	0.00255	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR ligand binding—CXCL8—malignant glioma	0.000197	0.00253	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—MMP3—malignant glioma	0.000197	0.00253	CbGpPWpGaD
Ticagrelor—CYP3A4—Metapathway biotransformation—CYP2C18—malignant glioma	0.000196	0.00252	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—JAG2—malignant glioma	0.000188	0.00242	CbGpPWpGaD
Ticagrelor—P2RY12—Hemostasis—RAF1—malignant glioma	0.000188	0.00241	CbGpPWpGaD
Ticagrelor—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—malignant glioma	0.000186	0.00238	CbGpPWpGaD
Ticagrelor—P2RY12—Hemostasis—PIK3CB—malignant glioma	0.000184	0.00236	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—RTEL1—malignant glioma	0.000183	0.00235	CbGpPWpGaD
Ticagrelor—ABCB1—Allograft Rejection—IFNG—malignant glioma	0.000182	0.00234	CbGpPWpGaD
Ticagrelor—ABCB1—Transmembrane transport of small molecules—ATP1B2—malignant glioma	0.00018	0.0023	CbGpPWpGaD
Ticagrelor—P2RY12—Platelet activation, signaling and aggregation—AKT1—malignant glioma	0.000177	0.00228	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—NTRK1—malignant glioma	0.000175	0.00225	CbGpPWpGaD
Ticagrelor—ABCB1—Transmembrane transport of small molecules—APOD—malignant glioma	0.000175	0.00224	CbGpPWpGaD
Ticagrelor—CYP3A4—Tryptophan metabolism—MDM2—malignant glioma	0.000172	0.00221	CbGpPWpGaD
Ticagrelor—ABCB1—Allograft Rejection—CXCL8—malignant glioma	0.00017	0.00217	CbGpPWpGaD
Ticagrelor—P2RY12—Hemostasis—IL2—malignant glioma	0.000169	0.00216	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—malignant glioma	0.000163	0.00209	CbGpPWpGaD
Ticagrelor—ABCB1—Allograft Rejection—IL1B—malignant glioma	0.000163	0.00209	CbGpPWpGaD
Ticagrelor—ABCB1—Allograft Rejection—CASP3—malignant glioma	0.000162	0.00208	CbGpPWpGaD
Ticagrelor—ABCB1—Allograft Rejection—IL2—malignant glioma	0.000162	0.00208	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN2B—malignant glioma	0.000161	0.00207	CbGpPWpGaD
Ticagrelor—CYP3A4—Biological oxidations—GSTT1—malignant glioma	0.000161	0.00206	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—H3F3A—malignant glioma	0.000159	0.00204	CbGpPWpGaD
Ticagrelor—ABCB1—HIF-1-alpha transcription factor network—VEGFA—malignant glioma	0.000159	0.00204	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR downstream signaling—F2—malignant glioma	0.000158	0.00203	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—CXCR3—malignant glioma	0.000158	0.00202	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—YWHAE—malignant glioma	0.000154	0.00197	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—NTRK2—malignant glioma	0.000154	0.00197	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—FLT1—malignant glioma	0.000153	0.00196	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—DUSP6—malignant glioma	0.000152	0.00195	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR downstream signaling—PIK3CG—malignant glioma	0.000152	0.00194	CbGpPWpGaD
Ticagrelor—CYP3A4—Biological oxidations—PTGS1—malignant glioma	0.000151	0.00193	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—JAG1—malignant glioma	0.00015	0.00193	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—NOTCH3—malignant glioma	0.00015	0.00192	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—FBXW7—malignant glioma	0.000147	0.00189	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—PDGFRA—malignant glioma	0.000147	0.00188	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—BDKRB2—malignant glioma	0.000144	0.00185	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—F2—malignant glioma	0.000144	0.00184	CbGpPWpGaD
Ticagrelor—P2RY12—Hemostasis—VEGFA—malignant glioma	0.000143	0.00184	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR downstream signaling—AKT2—malignant glioma	0.000139	0.00178	CbGpPWpGaD
Ticagrelor—ABCB1—Allograft Rejection—VEGFA—malignant glioma	0.000138	0.00177	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—PIK3CG—malignant glioma	0.000138	0.00176	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—PTPN11—malignant glioma	0.000135	0.00173	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—NOTCH2—malignant glioma	0.000134	0.00172	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR downstream signaling—PIK3CD—malignant glioma	0.000133	0.00171	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—KNG1—malignant glioma	0.000131	0.00168	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—FGFR1—malignant glioma	0.000131	0.00168	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—AKT2—malignant glioma	0.000126	0.00161	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—NTRK1—malignant glioma	0.000125	0.00161	CbGpPWpGaD
Ticagrelor—P2RY12—Hemostasis—KRAS—malignant glioma	0.000122	0.00156	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—PIK3CD—malignant glioma	0.000121	0.00155	CbGpPWpGaD
Ticagrelor—ABCB1—Allograft Rejection—TNF—malignant glioma	0.000118	0.00151	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—BAD—malignant glioma	0.000117	0.0015	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—MMP3—malignant glioma	0.000116	0.00149	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR downstream signaling—PIK3CB—malignant glioma	0.000116	0.00149	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—CDKN2B—malignant glioma	0.000115	0.00148	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—APC—malignant glioma	0.000114	0.00146	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—RTEL1—malignant glioma	0.000113	0.00145	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—EGF—malignant glioma	0.000112	0.00144	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—PTK2—malignant glioma	0.000112	0.00144	CbGpPWpGaD
Ticagrelor—P2RY12—Hemostasis—PIK3CA—malignant glioma	0.000112	0.00144	CbGpPWpGaD
Ticagrelor—CYP3A4—Biological oxidations—GSTP1—malignant glioma	0.000112	0.00143	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR downstream signaling—CXCL8—malignant glioma	0.000112	0.00143	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—HES1—malignant glioma	0.00011	0.00141	CbGpPWpGaD
Ticagrelor—CYP3A4—Metapathway biotransformation—GSTP1—malignant glioma	0.00011	0.00141	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—NCOR1—malignant glioma	0.000109	0.0014	CbGpPWpGaD
Ticagrelor—P2RY12—Hemostasis—TP53—malignant glioma	0.000108	0.00139	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—RAF1—malignant glioma	0.000108	0.00138	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR downstream signaling—IL2—malignant glioma	0.000107	0.00137	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—PIK3CB—malignant glioma	0.000105	0.00135	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—COX8A—malignant glioma	0.000105	0.00135	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—PDGFRA—malignant glioma	0.000105	0.00134	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—SPP1—malignant glioma	0.000102	0.0013	CbGpPWpGaD
Ticagrelor—ABCB1—HIF-1-alpha transcription factor network—AKT1—malignant glioma	0.000102	0.0013	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—CXCL8—malignant glioma	0.000101	0.0013	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—IL2—malignant glioma	9.68e-05	0.00124	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—TERT—malignant glioma	9.65e-05	0.00124	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—FGF2—malignant glioma	9.57e-05	0.00123	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—PDGFB—malignant glioma	9.42e-05	0.00121	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—FGFR1—malignant glioma	9.37e-05	0.0012	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—HIF1A—malignant glioma	9.23e-05	0.00118	CbGpPWpGaD
Ticagrelor—P2RY12—Hemostasis—AKT1—malignant glioma	9.15e-05	0.00117	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—malignant glioma	9.09e-05	0.00116	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—malignant glioma	8.95e-05	0.00115	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—ASMT—malignant glioma	8.95e-05	0.00115	CbGpPWpGaD
Ticagrelor—ABCB1—Transmembrane transport of small molecules—TFRC—malignant glioma	8.94e-05	0.00115	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—CAV1—malignant glioma	8.92e-05	0.00114	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—malignant glioma	8.92e-05	0.00114	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—malignant glioma	8.83e-05	0.00113	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—KDR—malignant glioma	8.82e-05	0.00113	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—malignant glioma	8.63e-05	0.00111	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—F2—malignant glioma	8.49e-05	0.00109	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—FN1—malignant glioma	8.49e-05	0.00109	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—BCAN—malignant glioma	8.41e-05	0.00108	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—BAD—malignant glioma	8.39e-05	0.00108	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—NOTCH1—malignant glioma	8.31e-05	0.00107	CbGpPWpGaD
Ticagrelor—ABCB1—Transmembrane transport of small molecules—SLC5A5—malignant glioma	8.21e-05	0.00105	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—CD80—malignant glioma	8.14e-05	0.00104	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—PIK3CG—malignant glioma	8.13e-05	0.00104	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—APC—malignant glioma	8.13e-05	0.00104	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—EGF—malignant glioma	8.03e-05	0.00103	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—malignant glioma	8.01e-05	0.00103	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—PTPN11—malignant glioma	7.99e-05	0.00102	CbGpPWpGaD
Ticagrelor—ABCB1—Transmembrane transport of small molecules—SLC6A3—malignant glioma	7.82e-05	0.001	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—BRAF—malignant glioma	7.64e-05	0.000979	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—malignant glioma	7.53e-05	0.000965	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—AKT2—malignant glioma	7.44e-05	0.000953	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—EGFR—malignant glioma	7.41e-05	0.000949	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—PIK3CD—malignant glioma	7.15e-05	0.000916	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR downstream signaling—PIK3CA—malignant glioma	7.08e-05	0.000907	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—KRAS—malignant glioma	7e-05	0.000897	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—FGF2—malignant glioma	6.84e-05	0.000877	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—malignant glioma	6.8e-05	0.000872	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—IDH2—malignant glioma	6.78e-05	0.000869	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—COX8A—malignant glioma	6.48e-05	0.000831	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—PIK3CA—malignant glioma	6.43e-05	0.000824	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—MDM2—malignant glioma	6.4e-05	0.000821	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—RAF1—malignant glioma	6.38e-05	0.000818	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—CYP2B6—malignant glioma	6.37e-05	0.000817	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—ERBB2—malignant glioma	6.31e-05	0.000809	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—malignant glioma	6.26e-05	0.000802	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—PIK3CB—malignant glioma	6.23e-05	0.000798	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—malignant glioma	6.12e-05	0.000784	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—CXCL8—malignant glioma	5.99e-05	0.000767	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—IDH1—malignant glioma	5.83e-05	0.000747	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—malignant glioma	5.83e-05	0.000747	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR downstream signaling—AKT1—malignant glioma	5.78e-05	0.000741	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—malignant glioma	5.78e-05	0.000741	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—CASP3—malignant glioma	5.73e-05	0.000734	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—IL2—malignant glioma	5.72e-05	0.000733	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—SPHK1—malignant glioma	5.64e-05	0.000723	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—CYP2C18—malignant glioma	5.53e-05	0.000709	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—ASMT—malignant glioma	5.51e-05	0.000707	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—MMP9—malignant glioma	5.41e-05	0.000694	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—PTEN—malignant glioma	5.38e-05	0.00069	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—malignant glioma	5.31e-05	0.000681	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—AKT1—malignant glioma	5.25e-05	0.000673	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—BCAN—malignant glioma	5.18e-05	0.000664	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—malignant glioma	5.14e-05	0.000659	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—VEGFA—malignant glioma	4.86e-05	0.000623	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—STAT3—malignant glioma	4.81e-05	0.000617	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—MYC—malignant glioma	4.47e-05	0.000573	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—GSTT1—malignant glioma	4.47e-05	0.000573	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—EGFR—malignant glioma	4.37e-05	0.000561	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—malignant glioma	4.34e-05	0.000556	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—PTGS1—malignant glioma	4.19e-05	0.000537	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—IDH2—malignant glioma	4.18e-05	0.000535	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—KRAS—malignant glioma	4.13e-05	0.00053	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—CYP2B6—malignant glioma	3.93e-05	0.000503	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—BCHE—malignant glioma	3.89e-05	0.000499	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—SLC5A5—malignant glioma	3.85e-05	0.000493	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—PIK3CA—malignant glioma	3.8e-05	0.000487	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—TP53—malignant glioma	3.67e-05	0.000471	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—IDH1—malignant glioma	3.59e-05	0.00046	CbGpPWpGaD
Ticagrelor—ABCB1—Transmembrane transport of small molecules—RAF1—malignant glioma	3.54e-05	0.000454	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—SPHK1—malignant glioma	3.48e-05	0.000446	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—CYP2C18—malignant glioma	3.41e-05	0.000437	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—AKT1—malignant glioma	3.1e-05	0.000398	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—GSTP1—malignant glioma	3.1e-05	0.000397	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—CAT—malignant glioma	3.02e-05	0.000386	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—NCOR1—malignant glioma	2.85e-05	0.000365	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—GSTT1—malignant glioma	2.75e-05	0.000353	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—PTGS1—malignant glioma	2.58e-05	0.000331	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—BCHE—malignant glioma	2.4e-05	0.000308	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—SLC5A5—malignant glioma	2.37e-05	0.000304	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—CAV1—malignant glioma	2.32e-05	0.000298	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—PIK3CG—malignant glioma	2.11e-05	0.000271	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—PPARG—malignant glioma	2.04e-05	0.000262	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—GSTP1—malignant glioma	1.91e-05	0.000245	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—PIK3CD—malignant glioma	1.86e-05	0.000238	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—CAT—malignant glioma	1.86e-05	0.000238	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—NCOR1—malignant glioma	1.75e-05	0.000225	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—PIK3CB—malignant glioma	1.62e-05	0.000208	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—PTGS2—malignant glioma	1.61e-05	0.000206	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—CAV1—malignant glioma	1.43e-05	0.000183	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—PTEN—malignant glioma	1.4e-05	0.000179	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—PIK3CG—malignant glioma	1.3e-05	0.000167	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—PPARG—malignant glioma	1.26e-05	0.000161	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—PIK3CD—malignant glioma	1.15e-05	0.000147	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—PIK3CB—malignant glioma	9.98e-06	0.000128	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—PTGS2—malignant glioma	9.89e-06	0.000127	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—PIK3CA—malignant glioma	9.88e-06	0.000127	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—PTEN—malignant glioma	8.62e-06	0.000111	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—AKT1—malignant glioma	8.07e-06	0.000103	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—PIK3CA—malignant glioma	6.08e-06	7.8e-05	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—AKT1—malignant glioma	4.97e-06	6.37e-05	CbGpPWpGaD
